Raymond James & Associates’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$22.2M Buy
233,493
+23,986
+11% +$2.2M 0.01% 763
2024
Q2
$18.9M Sell
209,507
-1,549
-0.7% -$137K 0.01% 810
2024
Q1
$18.9M Buy
211,056
+7,584
+4% +$640K 0.01% 806
2023
Q4
$16.6M Buy
203,472
+23,918
+13% +$1.81M 0.01% 821
2023
Q3
$13.2M Buy
179,554
+24,941
+16% +$1.89M 0.01% 881
2023
Q2
$11.6M Buy
154,613
+7,131
+5% +$510K 0.01% 968
2023
Q1
$10.5M Sell
147,482
-14,682
-9% -$1.04M 0.01% 996
2022
Q4
$11M Buy
162,164
+57,426
+55% +$3.92M 0.01% 945
2022
Q3
$6.53M Buy
104,738
+4,851
+5% +$333K 0.01% 1203
2022
Q2
$6.5M Buy
+99,887
New +$7.09M 0.01% 1229

Other funds holding AVUS

Raymond James & Associates's AVUS Position: Q3 2024 in Review

Raymond James & Associates increased its Avantis US Equity ETF (AVUS) stake by 11% in Q3 2024, buying an estimated $2.2M and bringing the position to 233,493 shares worth $22.2M. The position accounts for 0.01% of the portfolio, ranked #763.

Raymond James & Associates first reported a position in AVUS in Q2 2022 and has held it in 10 quarters since. 378 funds tracked by Wall St. Rank hold AVUS as of Q3 2024.

  • Raymond James & Associates held 233,493 shares of Avantis US Equity ETF worth $22.2M as of Q3 2024.
  • Raymond James & Associates bought 23,986 Avantis US Equity ETF shares in Q3 2024, an estimated $2.2M.
  • Avantis US Equity ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #763 holding.
  • Raymond James & Associates first reported a position in Avantis US Equity ETF in Q2 2022 and has held it in 10 quarters since.
  • 378 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.